Pyott David E I
- SEC CIK
- 0001051578
In the past year, 1 open-market sale filing worth $1.15M and no purchases.
Current role at each company
- TARS Tarsus Pharmaceuticals, Inc.Directoras of Sep 17, 2026
- ALNY Alnylam Pharmaceuticals, Inc.Directoras of Jun 3, 2026
- PLRX Pliant Therapeutics, Inc.Directoras of Jun 9, 2025
- BMRN Biomarin Pharmaceutical IncDirectoras of May 23, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.15M
- 1 filing
- Net
- −$1.15M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Pyott David E I as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ALNY Alnylam Pharmaceuticals, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2026 (view filing) | Jun 1 | 2 days | Pyott David E IDirector | SSale | −3.83K | $299.18 | −$1.15M | −70.8%1.58K after | 5 lots10b5-1 |
| Mar 25, 2025 (view filing) | Mar 24 | 1 day | Pyott David E IDirector | SSale | −7.44K | $299.00 | −$2.22M | −98.2%136 after | 10b5-1 |
| Jun 26, 2024 (view filing) | Jun 24 | 2 days | Pyott David E IDirector | SSale | −32.5K | $220.69 | −$7.16M | −99.6%136 after | 3 lots10b5-1 |